Albenza: Effective Treatment for Parasitic Worm Infections
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.52 | $47.04 (0%) | 🛒 Add to cart |
| 120 | $0.46 | $62.71 $55.04 (12%) | 🛒 Add to cart |
| 180 | $0.41 | $94.07 $73.06 (22%) | 🛒 Add to cart |
| 270 | $0.37 | $141.11 $99.08 (30%) | 🛒 Add to cart |
| 360 | $0.36
Best per pill | $188.14 $129.10 (31%) | 🛒 Add to cart |
Synonyms | |||
Albenza (albendazole) is a broad-spectrum anthelmintic medication prescribed for the treatment of a variety of parasitic worm infections. It works by inhibiting the polymerization of beta-tubulin, disrupting the energy metabolism of helminths, leading to their immobilization and death. This medication is essential in managing conditions such as neurocysticercosis and hydatid disease, offering a critical therapeutic option backed by clinical evidence. Proper usage under medical supervision ensures optimal efficacy and minimizes potential risks.
Features
- Active ingredient: Albendazole 400 mg per tablet
- Broad-spectrum anthelmintic activity
- Inhibits microtubule polymerization in parasites
- Available in oral tablet formulation
- Requires prescription for use
- Manufactured under strict pharmaceutical standards
Benefits
- Effectively eliminates a wide range of parasitic worm infections
- Reduces risk of complications from neurocysticercosis, such as seizures
- Helps resolve hydatid cysts, preventing organ damage
- Contributes to decreased transmission of parasites in communities
- Supports recovery and improved quality of life post-treatment
- Well-established safety profile when used as directed
Common use
Albenza is commonly prescribed for the treatment of infections caused by tapeworms, including neurocysticercosis—an infection of the central nervous system with larval cysts of Taenia solium—and cystic hydatid disease of the liver, lung, and peritoneum caused by the larval form of the dog tapeworm, Echinococcus granulosus. It is also used off-label for other helminthic infections such as giardiasis, ascariasis, and hookworm infections, depending on geographic prevalence and clinical judgment.
Dosage and direction
Dosage of Albenza varies based on the type of infection, patient weight, and clinical context. For neurocysticercosis, the recommended dose is 400 mg twice daily with meals for 8–30 days. For hydatid disease, the dose is weight-based: patients weighing 60 kg or more should take 400 mg twice daily, while those under 60 kg should take 15 mg/kg/day divided into two doses, not to exceed 800 mg daily. Treatment cycles may be repeated, as determined by a healthcare provider. Always take with a fatty meal to enhance absorption.
Precautions
- Use with caution in patients with hepatic impairment; monitor liver function tests.
- May cause fetal harm; avoid use in pregnancy unless potential benefit justifies risk.
- Blood counts should be monitored due to risk of neutropenia or pancytopenia.
- Use effective contraception during and for one month after treatment in women of childbearing potential.
- Not recommended during breastfeeding due to secretion in milk.
- Inform your healthcare provider of all current medications to avoid interactions.
Contraindications
Albenza is contraindicated in patients with known hypersensitivity to albendazole, benzimidazole derivatives, or any component of the formulation. It should not be used during pregnancy unless clearly necessary and under strict medical supervision, due to teratogenic risks. Avoid in patients with significant hepatic disease without close monitoring.
Possible side effect
Common side effects may include:
- Abdominal pain
- Nausea or vomiting
- Headache
- Dizziness
- Reversible alopecia
- Increased liver enzymes
Rare but serious side effects can include:
- Severe skin reactions
- Bone marrow suppression (neutropenia, agranulocytosis)
- Elevated intracranial pressure
- Hepatitis
Drug interaction
Albenza may interact with:
- Dexamethasone, cimetidine, and praziquantel, which can increase albendazole sulfoxide levels.
- Other hepatotoxic drugs, increasing risk of liver damage.
- Antiepileptics such as carbamazepine, phenytoin, and phenobarbital, which may reduce albendazole levels.
- Theophylline; monitor levels if co-administered.
- Oral contraceptives; additional non-hormonal contraception is advised.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to catch up. Resume the regular dosing schedule. Consult a healthcare provider if unsure.
Overdose
In case of suspected overdose, seek immediate medical attention. Symptoms may include severe nausea, vomiting, drowsiness, or altered mental status. Treatment is supportive; there is no specific antidote. Gastric lavage or activated charcoal may be considered if ingestion was recent.
Storage
Store Albenza tablets at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized dosage recommendations. Do not initiate or discontinue medication without medical supervision.
Reviews
Clinical studies and patient reports generally affirm the efficacy of Albenza in treating parasitic infections, with many noting significant symptom improvement. Some users report mild gastrointestinal discomfort, which often resolves. Adherence to prescribed regimens and follow-up is emphasized for best outcomes.